# A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy

> **NCT07091994** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 144 (estimated)

## Conditions studied

- Ischemic Stroke, Acute
- Active Malignancies

## Interventions

- **DRUG:** edaravone dexborneol injection
- **DRUG:** Standard therapeutic protocol

## Key facts

- **NCT ID:** NCT07091994
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07091994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07091994, "A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07091994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*